Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aron Goldhirsch

Showing results (81-90 of 283) with videos related to

Pageof 29
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93, Olivia Pagani, Shari Gelber, et al.
Journal of Surgical Oncology|September 13, 2006
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcomeOreste Gentilini, Mattia Intra, Sara Gandini, et al.
BMC Cancer|September 19, 2006
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancerLaura Orlando, Anna Cardillo, Raffaella Ghisini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancerMarco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
International Journal of Clinical Oncology|April 12, 2014
Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case seriesGaetano Aurilio, Rossella Graffeo, Vincenzo Bagnardi, et al.
European Journal of Haematology|April 20, 2004
Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treatDaniele Laszlo, Alberto Agazzi, Aron Goldhirsch, et al.
Journal of the National Cancer Institute|August 31, 2007
Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trialNicola Fazio, Roberto Biffi, Giuseppe Curigliano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93, Marco Colleoni, Shari Gelber, et al.
Cancer Treatment Reviews|November 5, 2013
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunitiesAngela Esposito, Alberto Bardelli, Carmen Criscitiello, et al.
Nature|March 9, 2007
Keeping faith with trial volunteersMartine Piccart, Aron Goldhirsch, William Wood, et al.
Pageof 29

Showing results (81-90 of 283) with videos related to

Sort By:
Pageof 29
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93, Olivia Pagani, Shari Gelber, et al.
Journal of Surgical Oncology|September 13, 2006
Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcomeOreste Gentilini, Mattia Intra, Sara Gandini, et al.
BMC Cancer|September 19, 2006
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancerLaura Orlando, Anna Cardillo, Raffaella Ghisini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancerMarco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.
International Journal of Clinical Oncology|April 12, 2014
Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case seriesGaetano Aurilio, Rossella Graffeo, Vincenzo Bagnardi, et al.
European Journal of Haematology|April 20, 2004
Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treatDaniele Laszlo, Alberto Agazzi, Aron Goldhirsch, et al.
Journal of the National Cancer Institute|August 31, 2007
Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trialNicola Fazio, Roberto Biffi, Giuseppe Curigliano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93, Marco Colleoni, Shari Gelber, et al.
Cancer Treatment Reviews|November 5, 2013
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunitiesAngela Esposito, Alberto Bardelli, Carmen Criscitiello, et al.
Nature|March 9, 2007
Keeping faith with trial volunteersMartine Piccart, Aron Goldhirsch, William Wood, et al.
Pageof 29